JP4190394B2 - 血液透析器 - Google Patents
血液透析器 Download PDFInfo
- Publication number
- JP4190394B2 JP4190394B2 JP2003371099A JP2003371099A JP4190394B2 JP 4190394 B2 JP4190394 B2 JP 4190394B2 JP 2003371099 A JP2003371099 A JP 2003371099A JP 2003371099 A JP2003371099 A JP 2003371099A JP 4190394 B2 JP4190394 B2 JP 4190394B2
- Authority
- JP
- Japan
- Prior art keywords
- hollow fiber
- fiber membrane
- flow rate
- blood
- hemodialyzer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000012528 membrane Substances 0.000 claims description 128
- 239000012510 hollow fiber Substances 0.000 claims description 118
- 238000001914 filtration Methods 0.000 claims description 94
- 239000008280 blood Substances 0.000 claims description 60
- 210000004369 blood Anatomy 0.000 claims description 60
- 230000017531 blood circulation Effects 0.000 claims description 34
- 238000011049 filling Methods 0.000 claims description 22
- 238000000108 ultra-filtration Methods 0.000 claims description 14
- 238000007873 sieving Methods 0.000 claims description 11
- 238000000034 method Methods 0.000 description 52
- 238000005259 measurement Methods 0.000 description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 40
- 239000007788 liquid Substances 0.000 description 30
- 238000000502 dialysis Methods 0.000 description 20
- 102000004169 proteins and genes Human genes 0.000 description 18
- 108090000623 proteins and genes Proteins 0.000 description 18
- 238000000691 measurement method Methods 0.000 description 15
- 239000000523 sample Substances 0.000 description 14
- 238000011088 calibration curve Methods 0.000 description 13
- 239000002245 particle Substances 0.000 description 13
- 229920005989 resin Polymers 0.000 description 13
- 239000011347 resin Substances 0.000 description 13
- 238000011282 treatment Methods 0.000 description 12
- 239000000126 substance Substances 0.000 description 11
- 238000010586 diagram Methods 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 7
- 238000001631 haemodialysis Methods 0.000 description 7
- 230000000322 hemodialysis Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 229920002492 poly(sulfone) Polymers 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000002166 wet spinning Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000035699 permeability Effects 0.000 description 5
- 238000004382 potting Methods 0.000 description 5
- 238000005520 cutting process Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- -1 polyethylene Polymers 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 230000007012 clinical effect Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000002016 colloidosmotic effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000002615 hemofiltration Methods 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 229920005749 polyurethane resin Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 208000006784 Cutaneous Fistula Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000001891 gel spinning Methods 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000002074 melt spinning Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920006122 polyamide resin Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000009719 polyimide resin Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920005672 polyolefin resin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003371099A JP4190394B2 (ja) | 2003-10-30 | 2003-10-30 | 血液透析器 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003371099A JP4190394B2 (ja) | 2003-10-30 | 2003-10-30 | 血液透析器 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005131123A JP2005131123A (ja) | 2005-05-26 |
| JP2005131123A5 JP2005131123A5 (enExample) | 2008-09-18 |
| JP4190394B2 true JP4190394B2 (ja) | 2008-12-03 |
Family
ID=34647893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003371099A Expired - Fee Related JP4190394B2 (ja) | 2003-10-30 | 2003-10-30 | 血液透析器 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4190394B2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4940576B2 (ja) * | 2005-06-10 | 2012-05-30 | 東洋紡績株式会社 | 中空糸膜および血液浄化器 |
| JP4889109B2 (ja) * | 2006-10-13 | 2012-03-07 | 旭化成クラレメディカル株式会社 | 中空糸膜型血液浄化装置 |
| JP5358896B2 (ja) * | 2007-03-16 | 2013-12-04 | 東レ株式会社 | 中空糸膜およびこれを内蔵してなる血液浄化器 |
| US8287724B2 (en) * | 2007-07-05 | 2012-10-16 | Baxter International Inc. | Dialysis fluid measurement systems using conductive contacts |
| EP3809417A1 (en) * | 2019-10-14 | 2021-04-21 | Gambro Lundia AB | Determining internal filtration rate within a capillary dialyzer |
-
2003
- 2003-10-30 JP JP2003371099A patent/JP4190394B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005131123A (ja) | 2005-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2326410B1 (en) | Diffusion and/or filtration device | |
| JP4373684B2 (ja) | フィルタ目詰まり状況監視装置およびベッドサイドシステム | |
| EP1547628B1 (en) | Plasma purification membrane and plasma purification system | |
| US6533747B1 (en) | Extracorporeal circuit for peripheral vein fluid removal | |
| Petitclerc et al. | Non-invasive monitoring of effective dialysis dose delivered to the haemodialysis patient | |
| JP6002136B2 (ja) | 血液浄化装置 | |
| CN1747755A (zh) | 血液治疗装置 | |
| CN106999644B (zh) | 用于监控血细胞比容和/或血红蛋白值的时间变化的透析机 | |
| US20050203493A1 (en) | Method for calculating filter clogging factor and bed-side system | |
| JP4190394B2 (ja) | 血液透析器 | |
| JP4414925B2 (ja) | 医療用横流式送液ポンプ及び横流式送液ポンプ付医療機器 | |
| JP4992104B2 (ja) | 血液濾過または血液濾過透析用のモジュール | |
| JP6777383B2 (ja) | 中空糸膜モジュール及びその製造方法 | |
| JP7038358B2 (ja) | 血液浄化装置 | |
| JP4144844B2 (ja) | 中空糸膜型透析濾過器 | |
| JP2004081833A (ja) | フィルタ目詰まり指数算出方法、フィルタ目詰まり監視方法及び装置、並びにベッドサイドシステム | |
| EP3789059B1 (en) | Air trap chamber and extracorporeal circulation circuit | |
| JP2005253747A (ja) | 血液浄化装置及びその交換型血液浄化デバイスユニット | |
| JP2003220134A (ja) | 中空糸膜型透析濾過器 | |
| EP3900814B1 (en) | Dialyzer header cap | |
| EP4076575A1 (en) | Flow chamber with helical flow path | |
| JP3130331B2 (ja) | 再生セルロース製中空糸膜および人工透析器 | |
| TWI906235B (zh) | 血液治療透析治療系統及其中之離心血液泵 | |
| JP7357343B2 (ja) | 血液浄化装置 | |
| JPH0970525A (ja) | ポリスルホン系選択透過性分離膜 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20061013 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080805 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080912 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080916 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110926 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4190394 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110926 Year of fee payment: 3 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110926 Year of fee payment: 3 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110926 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120926 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130926 Year of fee payment: 5 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130926 Year of fee payment: 5 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| LAPS | Cancellation because of no payment of annual fees |